In-stent Thrombosis and COVID-19 Infection: Current Insights on the Mechanistic Relationship.
COVID-19
Stent thrombosis
anti-thrombotic therapy
antiplatelet
coronary artery disease
drug-eluting stent implantation
Journal
Current cardiology reviews
ISSN: 1875-6557
Titre abrégé: Curr Cardiol Rev
Pays: United Arab Emirates
ID NLM: 101261935
Informations de publication
Date de publication:
2023
2023
Historique:
received:
03
12
2021
revised:
16
02
2022
accepted:
02
03
2022
pmc-release:
01
01
2024
pubmed:
14
5
2022
medline:
9
2
2023
entrez:
13
5
2022
Statut:
ppublish
Résumé
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been demonstrated as a major risk factor in inducing coronary stent thrombosis due to its propensity to create a pro-thrombotic state. This review explores the mechanisms that may contribute to the increased thrombosis risk seen in COVID-19. Furthermore, we discuss the patient and haematological factors that predispose to an increased risk of stent thrombosis, as well as the role of certain antiplatelet and anticoagulation therapies, including ticagrelor and enoxaparin, that may reduce the likelihood and severity of in-stent thrombosis, in SARS-CoV-2 infection. To counter the proinflammatory and pro-thrombotic state shown in COVID-19, anti-thrombotic therapy in the future may be optimised using point-of-care platelet inhibition testing and inflammation-modifying therapies. Large-scale randomised trials with long-term follow-up are increasingly necessary to assess the intersection of COVID-19 and stent optimisation as well as the reduction of stent thrombosis after drug-eluting stent (DES) implantation.
Identifiants
pubmed: 35549872
pii: CCR-EPUB-123446
doi: 10.2174/1573403X18666220512142019
pmc: PMC10201881
doi:
Substances chimiques
Platelet Aggregation Inhibitors
0
Types de publication
Review
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e120522204669Informations de copyright
Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.
Références
Adv Intern Med. 2000;45:419-29
pubmed: 10635057
Thromb Res. 2014 Jul;134(1):105-10
pubmed: 24856643
Cardiovasc Revasc Med. 2020 Feb;21(2):213-221
pubmed: 31147259
Pharmacol Rep. 2021 Dec;73(6):1551-1564
pubmed: 34283374
J Vasc Surg Cases Innov Tech. 2020 Sep;6(3):454-459
pubmed: 32835150
Cardiovasc Revasc Med. 2022 Feb;35:129-138
pubmed: 33863660
Circ Cardiovasc Qual Outcomes. 2020 Apr;13(4):e006631
pubmed: 32182131
Am J Physiol Cell Physiol. 2010 Jul;299(1):C97-110
pubmed: 20375277
J Clin Invest. 2020 May 1;130(5):2620-2629
pubmed: 32217835
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
N Engl J Med. 2020 Jul 16;383(3):288-290
pubmed: 32369280
J Clin Invest. 1995 Mar;95(3):995-1001
pubmed: 7884001
Korean Circ J. 2020 Jul;50(7):632-633
pubmed: 32588573
J Clin Med. 2019 May 22;8(5):
pubmed: 31121897
Am J Cardiol. 2020 Sep 15;131:1-6
pubmed: 32732010
N Engl J Med. 2007 Mar 8;356(10):1020-9
pubmed: 17296821
Int J Mol Sci. 2020 Feb 19;21(4):
pubmed: 32092903
Cardiovasc Drugs Ther. 2021 Apr;35(2):215-229
pubmed: 33074525
Lancet. 2002 Mar 9;359(9309):849-50
pubmed: 11897286
Biochem Biophys Res Commun. 2007 Jul 20;359(1):174-9
pubmed: 17533109
Heart Rhythm. 2020 Nov;17(11):1984-1990
pubmed: 32599178
Circulation. 2020 Jun 9;141(23):1903-1914
pubmed: 32297796
JAMA Cardiol. 2020 Oct 1;5(10):1195-1198
pubmed: 32639522
J Pathol. 2017 Sep;243(1):111-122
pubmed: 28678391
Shock. 2017 Jan;47(1):13-21
pubmed: 27984533
J Card Surg. 2020 Aug;35(8):1988-2008
pubmed: 32652713
Ann Hematol. 2020 Oct;99(10):2323-2328
pubmed: 32808105
J Thromb Haemost. 2020 Apr;18(4):844-847
pubmed: 32073213
Clin Immunol. 2020 Jul;216:108468
pubmed: 32445671
Microcirculation. 2014 Jul;21(5):401-7
pubmed: 24495184
Front Immunol. 2013 Apr 08;4:85
pubmed: 23580000
Thromb Res. 2016 Feb;138:114-120
pubmed: 26709040
Drugs. 2020 Oct;80(15):1553-1562
pubmed: 32803670
Heart. 2012 May;98(9):706-11
pubmed: 22523055
Int J Mol Sci. 2020 May 21;21(10):
pubmed: 32455533
Clin Res Cardiol. 2021 Feb;110(2):302-306
pubmed: 32430631
J Med Vasc. 2020 May;45(3):147-157
pubmed: 32402428
J Am Coll Cardiol. 2020 Sep 8;76(10):1168-1176
pubmed: 32679155
Heart. 2015 Jul;101(14):1126-32
pubmed: 25999588
Am J Cardiol. 2003 Apr 15;91(8):925-30
pubmed: 12686329
Intensive Care Med. 2020 Jun;46(6):1089-1098
pubmed: 32367170
Blood Rev. 2021 Jan;45:100707
pubmed: 32425294
Thromb Res. 2020 Jul;191:9-14
pubmed: 32353746
TH Open. 2020 Oct 07;4(4):e288-e299
pubmed: 33043235
Semin Immunopathol. 2017 Jul;39(5):517-528
pubmed: 28555385
Cell Mol Immunol. 2020 Jun;17(6):613-620
pubmed: 32203189
Thromb Res. 2014 May;133 Suppl 1:S28-31
pubmed: 24759136
Clin Chem Lab Med. 2020 Jun 25;58(7):1021-1028
pubmed: 32286245
Catheter Cardiovasc Interv. 2021 Feb 1;97(2):E241-E243
pubmed: 32352633
JACC Case Rep. 2020 Jul 15;2(9):1291-1296
pubmed: 32835270
J Am Coll Cardiol. 2014 Jun 17;63(23):2503-2509
pubmed: 24768873
Cardiovasc Diagn Ther. 2020 Aug;10(4):898-901
pubmed: 32968646
Transl Res. 2020 Jun;220:1-13
pubmed: 32299776
Cell Signal. 2019 Dec;64:109394
pubmed: 31472244
Front Immunol. 2019 Feb 01;10:119
pubmed: 30774631
Lancet. 2020 Mar 28;395(10229):1033-1034
pubmed: 32192578
Chin Med J (Engl). 2020 Jun 5;133(11):1261-1267
pubmed: 32209890
Proc (Bayl Univ Med Cent). 2020 Sep 8;34(1):175-177
pubmed: 33456191
Hypertension. 2010 Dec;56(6):1089-95
pubmed: 20975035
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Cell Host Microbe. 2020 Jun 10;27(6):992-1000.e3
pubmed: 32320677
Am J Hematol. 2020 Dec;95(12):1578-1589
pubmed: 32857878
Cureus. 2020 Sep 29;12(9):e10708
pubmed: 33133872
Platelets. 2021 Nov 17;32(8):1009-1017
pubmed: 34097572